Sign in
4

Changes in Ownership

Amylyx Pharmaceuticals, Inc. Filed Acc 0000899243-22-001527

Director bought 3,947 shares at $19.00 ($74,993)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
FONTEYNE PAUL R. Director 2022-01-06 Purchase +3,947 $19.00 $74,993 3,947 D
Derivatives
FONTEYNE PAUL R. Director 2022-01-06 Grant or award · Stock Option (Right to Buy) +8,400 8,400 D
Open-market purchases · 3,947 sh · avg $19.00 · $74,993
Loading xslF345X03/doc4.xml…